Dr. Raghuram Selvaraju is a Chairman at RELIEF THERAPEUTICS Holding AG, a Managing Director & Senior Healthcare Analyst at H. C. Wainwright & Co. LLC and a Managing Director-Equity Research at H C Wainwright & Co. His research focuses on the healthcare sector at H. C. Wainwright & Co. LLC.

Dr. Selvaraju possesses over a decade’s worth of experience in Healthcare Equity Research. Prior to joining H.C. Wainwright, he held Senior Research positions at MLV & Co., Aegis Capital, Hapoalim Securities USA and Rodman & Renshaw LLC.

Dr. Selvaraju’s educational background includes a Ph.D. in molecular neuroscience and cellular immunology, an M.S. degree in molecular biology from the University of Geneva in Switzerland, and an MBA from Cornell University.